Cargando…
A Pipeline for Drug Target Identification and Validation
Rapid and affordable tumor profiling has led to an explosion of genomic data that is facilitating the development of new cancer therapies. The potential of therapeutic strategies aimed at inactivating the oncogenic lesions that contribute to the aberrant survival and proliferation of tumor cells has...
Autores principales: | Manchado, Eusebio, Huang, Chun-Hao, Tasdemir, Nilgun, Tschaharganeh, Darjus F., Wilkinson, John E., Lowe, Scott W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469697/ https://www.ncbi.nlm.nih.gov/pubmed/28057848 http://dx.doi.org/10.1101/sqb.2016.81.031096 |
Ejemplares similares
-
Conditional Reverse Tet-Transactivator Mouse Strains for the Efficient Induction of TRE-Regulated Transgenes in Mice
por: Dow, Lukas E., et al.
Publicado: (2014) -
Chelator-Free Radiolabeling of SERRS Nanoparticles for Whole-Body PET and Intraoperative Raman Imaging
por: Wall, Matthew A., et al.
Publicado: (2017) -
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets
por: Li, Xiang, et al.
Publicado: (2022) -
Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015) -
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
por: Huang, Chun-Hao, et al.
Publicado: (2014)